chronic renal failure
Conditions
Interventions
None listed
Sponsors
Department of Healthcare Economics and Health Policy, Graduate School of Medicine, The University of Tokyo
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Index date(t0) is March 2016, when guidance/management fee for peripheral arterial disease of lower limb can be calculated. Patients who meet the following conditions starting from Index Date (t0). (1) Patient receiving dialysis at t0 (2) Patients aged 20 to 75 years at t0
Exclusion criteria
Exclusion criteria: (1) Patients who have undergone major amputation due to trauma or malignant tumors within the evaluation period (2) Patients with a history of malignant tumors (Treatment for malignant tumors has been performed before t0) (3) Patients who started to calculate the guidance/management fee for peripheral arterial disease of lower limb during the evaluation period (4) Dementia patients(Dementia treatment has been performed before t0) (5) Patients with mental disease(mental disease treatment has been performed before t0) (6) Patients who underwent kidney transplantation during the study period (April 2012-June 2019) (7) Patients with collagen disease, vasculitis, etc. (including rare diseases) (collagen disease, vasculitis, etc. treatment have been performed before t0) (8) Patients who started dialysis from January to March 2016 (9) Patients using a auxiliary artificial heart (using a auxiliary artificial heart before t0) (10) Patients undergoing EVT or bypass surgery (undergoing EVT or bypass surgery before t0)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Major amputation rate | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Cost-effectiveness of guidance/management fee for peripheral arterial disease 2. Patients rate undergoing major amputation, minor amputation, EVT and bypass surgery 3. Major amputation rate with and without minor amputation 4. Major amputation rate with or without ischemic limbs 5. Major amputation rate in patients with a history of major amputations 6. Major amputation rate in patients undergoing renal rehabilitation 7.Major amputation rate in patients with chronic renal failure due to diabetic nephropathy 8.Major amputation rate in patients with chronic renal failure due to nephrosclerosis 9.Major amputation rate in patients with chronic renal failure due to glomerulonephritis | — |
Countries
Japan
Contacts
Public ContactTomoyuki Takura
The University of Tokyo Department of Healthcare Economics and Health Policy, Graduate School of Medicine
Outcome results
None listed